STATEMENT – Innovative Health Seeks Permanent Injunction Against Johnson & Johnson Medtech’s Biosense Webster Following Landmark Antitrust Win
Motion filed includes evidence and testimony presented at trial demonstrating the lengths Johnson & Johnson MedTech’s Biosense Webster went to “crush” reprocessor competitors June 20, 2025 FOR IMMEDIATE RELEASE [Note to Editors: The case information
Triple Damages — $442M — Awarded to AMDR Member Innovative Health in Case Against Johnson & Johnson’s Biosense Webster Medical Technology Unit for Withholding Technical Support When Reprocessed Devices Were Used
[Washington, D.C. and Berlin, Germany / 5 June 2025] Today, Judge James V. Selna of the U.S. District Court for the Central District of California entered judgment in Innovative Health LLC v. Biosense Webster, Inc.,
STATEMENT On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Technology Unit
[Washington, D.C. and Berlin, Germany / 18 May 2025] Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals,